Aberrant regulation of FBW7 in cancer
Aberrant regulation of FBW7 in cancer |
https://doi.org/10.18632/oncotarget.1859
Lixia Wang,
Xiantao Ye,
Yueyong Liu,
Wenyi Wei,
and Zhiwei Wang
|
2000-2015 |
Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer
Epigenetic plasticity: A central regulator of epithelial-to-mesenchymal transition in cancer |
https://doi.org/10.18632/oncotarget.1875
Upasana Bedi,
Vivek Kumar Mishra,
David Wasilewski,
Christina Scheel,
and Steven A. Johnsen
|
2016-2029 |
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways
MDM2 antagonists synergize broadly and robustly with compounds targeting fundamental oncogenic signaling pathways |
https://doi.org/10.18632/oncotarget.1918
Anne Y. Saiki,
Sean Caenepeel,
Dongyin Yu,
Julie A. Lofgren,
Tao Osgood,
Rebecca Robertson,
Jude Canon,
Cheng Su,
Adrie Jones,
Xiaoning Zhao,
Chetan Deshpande,
Marc Payton,
Jebediah Ledell,
Paul E. Hughes,
and Jonathan D. Oliner
|
2030-2043 |
Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases
Polyubiquitylation of AMF requires cooperation between the gp78 and TRIM25 ubiquitin ligases |
https://doi.org/10.18632/oncotarget.1478
Ying Wang,
Seung-Wook Ha,
Tianpeng Zhang,
Dhong-Hyo Kho,
Avraham Raz,
and Youming Xie
|
2044-2051 |
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.1504
Valentina Folgiero,
Bianca M. Goffredo,
Perla Filippini,
Riccardo Masetti,
Giuseppina Bonanno,
Roberta Caruso,
Valentina Bertaina,
Angela Mastronuzzi,
Stefania Gaspari,
Marco Zecca,
Giovanni F Torelli,
Anna M Testi,
Andrea Pession,
Franco Locatelli,
and Sergio Rutella
|
2052-2064 |
The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells
The Polycomb group protein RING1B is overexpressed in ductal breast carcinoma and is required to sustain FAK steady state levels in breast cancer epithelial cells |
https://doi.org/10.18632/oncotarget.1779
Almudena Bosch,
Konstantina Panoutsopoulou,
Josep Maria Corominas,
Ramón Gimeno,
Gema Moreno-Bueno,
Juan Martín-Caballero,
Saleta Morales,
Tania Lobato,
Carles Martínez-Romero,
Eduardo F. Farias,
Xavier Mayol,
Amparo Cano,
and Inmaculada Hernández-Muñoz
|
2065-2076 |
Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway
Galectin-3 induces cell migration via a calcium-sensitive MAPK/ERK1/2 pathway |
https://doi.org/10.18632/oncotarget.1786
Xiaoge Gao,
Vitaly Balan,
Guihua Tai,
and Avraham Raz
|
2077-2084 |
SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells
SIRT1 promotes proliferation and inhibits the senescence-like phenotype in human melanoma cells |
https://doi.org/10.18632/oncotarget.1791
Mickaël Ohanna,
Caroline Bonet,
Karine Bille,
Maryline Allegra,
Irwin Davidson,
Philippe Bahadoran,
Jean-Philippe Lacour,
Robert Ballotti,
and Corine Bertolotto
|
2085-2095 |
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2
C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2 |
https://doi.org/10.18632/oncotarget.1815
Ji-Shiang Hung,
John Huang,
Yo-Chuen Lin,
Miao-Juei Huang,
Po-Huang Lee,
Hong-Shiee Lai,
Jin-Tung Liang,
and Min-Chuan Huang
|
2096-2106 |
Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine
Mapping of actionable mutations to histological subtype domains in lung adenocarcinoma: implications for precision medicine |
https://doi.org/10.18632/oncotarget.1840
Gavin M. Wright,
Hongdo Do,
Jonathan Weiss,
Naveed Alam,
Vivek Rathi,
Marzena Walkiewicz,
Thomas John,
Prudence Russell,
and Alexander Dobrovic
|
2107-2115 |
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites.
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. |
https://doi.org/10.18632/oncotarget.1845
Paola Monti,
Yari Ciribilli,
Alessandra Bisio,
Giorgia Foggetti,
Ivan Raimondi,
Paola Campomenosi,
Paola Menichini,
Gilberto Fronza,
and Alberto Inga
|
2116-2130 |
Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation
Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation |
https://doi.org/10.18632/oncotarget.1852
Samadhi Aparicio-Siegmund,
Jan Sommer,
Niloufar Monhasery,
Ralf Schwanbeck,
Eric Keil,
David Finkenstädt,
Klaus Pfeffer,
Stefan Rose-John,
Jürgen Scheller,
and Christoph Garbers
|
2131-2148 |
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer
The EF-hand calcium-binding protein tescalcin is a potential oncotarget in colorectal cancer |
https://doi.org/10.18632/oncotarget.1851
Yun Hee Kang,
Seung Ro Han,
Jong-Tae Kim,
Seon-Jin Lee,
Young Il Yeom,
Jeong-Ki Min,
Chul-Ho Lee,
Jae Wha Kim,
Suk Ran Yoon,
Do-Young Yoon,
Kwan Soo Hong,
Geum-Sook Hwang,
Hee Cheol Kim,
Young-Ha Lee,
and Hee Gu Lee
|
2149-2160 |
MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis
MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis |
https://doi.org/10.18632/oncotarget.1855
Hui-jie Huang,
Jun Liu,
Hu Hua,
San-en Li,
Jin Zhao,
Shen Yue,
Ting-ting Yu,
Yu-cui Jin,
and Steven Y. Cheng
|
2161-2175 |
Novel mechanism of JNK pathway activation by adenoviral E1A
Novel mechanism of JNK pathway activation by adenoviral E1A |
https://doi.org/10.18632/oncotarget.1860
Vasily S. Romanov,
Anna I. Brichkina,
Helen Morrison,
Tatiana V. Pospelova,
Valery A. Pospelov,
and Peter Herrlich
|
2176-2186 |
Minoxidil may suppress androgen receptor-related functions
Minoxidil may suppress androgen receptor-related functions |
https://doi.org/10.18632/oncotarget.1886
Cheng-Lung Hsu,
Jai-Shin Liu,
An-Chi Lin,
Chih-Hsun Yang,
Wen-Hung Chung,
and Wen-Guey Wu
|
2187-2197 |
Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor
Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor |
https://doi.org/10.18632/oncotarget.1889
Yozo Mitsui,
Hiroaki Yasumoto,
Taichi Nagami,
Miho Hiraki,
Naoko Arichi,
Noriyoshi Ishikawa,
Asuka Araki,
Riruke Maruyama,
Yuichiro Tanaka,
Rajvir Dahiya,
and Hiroaki Shiina
|
2198-2207 |
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes |
https://doi.org/10.18632/oncotarget.1893
Konrad Gabrusiewicz,
Dan Liu,
Nahir Cortes-Santiago,
Mohammad B. Hossain,
Charles A. Conrad,
Kenneth D. Aldape,
Gregory N. Fuller,
Frank C. Marini,
Marta M. Alonso,
Miguel Angel Idoate,
Mark R. Gilbert,
Juan Fueyo,
and Candelaria Gomez-Manzano
|
2208-2220 |
Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components
Multi-modality imaging to determine the cellular heterogeneity of nasopharyngeal carcinoma components |
https://doi.org/10.18632/oncotarget.1894
Weidong Zhang,
Yanling Zhang,
Shi Ke,
Mingjian Lu,
Guang Yang,
Tao Zhang,
Jianjun Han,
Zhenyin Liu,
Wei Wang,
Henry Ran,
Chaoxia Zou,
Shaofan Hu,
Guangtao Lei,
Chuanxing Li,
and Fujun Zhang
|
2221-2229 |
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer
A long non-coding RNA signature to improve prognosis prediction of colorectal cancer |
https://doi.org/10.18632/oncotarget.1895
Ye Hu,
Hao-Yan Chen,
Chen-Yang Yu,
Jie Xu,
Ji-Lin Wang,
Jin Qian,
Xi Zhang,
and Jing-Yuan Fang
|
2230-2242 |
Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior
Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior |
https://doi.org/10.18632/oncotarget.1896
Chih-Yen Chien,
Hsin-Ting Tsai,
Li-Jen Su,
Hui-Ching Chuang,
Li-Yen Shiu,
Chao-Cheng Huang,
Fu-Min Fang,
Chun-Chieh Yu,
Huei-Ting Su,
and Chang-Han Chen
|
2243-2262 |
Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 status
Combinatorial inhibition of Plk1 and PKCβ in cancer cells with different p53 status |
https://doi.org/10.18632/oncotarget.1897
Lisa Lange,
Sarah Keppner-Witter,
Juline Grigat,
and Birgit Spänkuch
|
2263-2275 |
Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a
Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a |
https://doi.org/10.18632/oncotarget.1902
Er-bao Zhang,
Rong Kong,
Dan-dan Yin,
Liang-hui You,
Ming Sun,
Liang Han,
Tong-peng Xu,
Rui Xia,
Jin-song Yang,
Wei De,
and Jin fei Chen
|
2276-2292 |
Multiplex genomic profiling of non–small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study
Multiplex genomic profiling of non–small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study |
https://doi.org/10.18632/oncotarget.1906
Isamu Okamoto,
Kazuko Sakai,
Satoshi Morita,
Hiroshige Yoshioka,
Hiroyasu Kaneda,
Koji Takeda,
Tomonori Hirashima,
Yoshihito Kogure,
Tatsuo Kimura,
Toshiaki Takahashi,
Shinji Atagi,
Takashi Seto,
Toshiyuki Sawa,
Masashi Yamamoto,
Miyako Satouchi,
Motoyasu Okuno,
Seisuke Nagase,
Koichi Takayama,
Keisuke Tomii,
Tadashi Maeda,
Satoshi Oizumi,
Shinji Fujii,
Yusaku Akashi,
Kazumi Nishino,
Noriyuki Ebi,
Kazuhiko Nakagawa,
Yoichi Nakanishi,
and Kazuto Nishio
|
2293-2304 |
Caspase-3 and Caspase-6 cleave STAT1 in leukemic cells
Caspase-3 and Caspase-6 cleave STAT1 in leukemic cells |
https://doi.org/10.18632/oncotarget.1911
Verena Licht,
Katrin Noack,
Bernhard Schlott,
Martin Förster,
Yvonne Schlenker,
Andreas Licht,
Oliver H. Krämer,
and Thorsten Heinzel
|
2305-2317 |
Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer
Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer |
https://doi.org/10.18632/oncotarget.1913
Hao Li,
Beiqin Yu,
Jianfang Li,
Liping Su,
Min Yan,
Zhenggang Zhu,
and Bingya Liu
|
2318-2329 |
CUL4A contributes to the biology of basal-like breast tumors through modulation of cell growth and antitumor immune response
CUL4A contributes to the biology of basal-like breast tumors through modulation of cell growth and antitumor immune response |
https://doi.org/10.18632/oncotarget.1915
Laura P. Saucedo-Cuevas,
Isabel Ruppen,
Pilar Ximénez-Embún,
Samuel Domingo,
Javier Gayarre,
Javier Muñoz,
Jose M. Silva,
María J. García,
and Javier Benítez
|
2330-2343 |